Extract notice to the Minister
Nemluvio (prurigo nodulaire)
Common name / Subject : némolizumab
Name of the manufacturer : Galderma
Form : Sol. Inj. S.C. (stylo)
Dosage : 30 mg / 0,49 ml
Name of the manufacturer : Galderma
Form : Sol. Inj. S.C. (stylo)
Dosage : 30 mg / 0,49 ml
Indication : Prurigo nodulaire modéré à grave
INESSS' Recommendation
Inscription - Sous conditions
Minister's decisions
Surseoir à la décision (2026-03-04)
Evaluation published on February 18, 2026
INESSSid: 26153
Recevable on February 24, 2025